September is World Alzheimer’s Awareness Month. As the recent death of Gene Wilder reminds us, Alzheimer’s afflicts millions of people every year.  In fact, as the 6th leading cause of death in the US, more people die of Alzheimer’s than breast cancer and prostate cancer combined. However, the latest word from Alzheimer’s researchers may be a source of hope for patients and families. A new drug in the early stages of testing, aducanumab, seems to be able to attack the toxic brain plaques that are thought to cause Alzheimer’s. If upcoming clinical trials can confirm these early results, this could be a game changer in the way we treat Alzheimer’s. To read, and hear, about this potentially life-altering research, check out this NPR report.